Papillenschwellung, Hydrozephalus und Diplopie – kein zeitlicher,
                    aber ein kausaler Zusammenhang?

F. Tonagel; K. Friebe; H. Wilhelm; C. Kernstock

doi:10.1055/s-0033-1350907

Klinische Monatsblätter für Augenheilkunde, Inhaltsverzeichnis

Klin Monbl Augenheilkd 2013; 230(11): 1122-1124
DOI: 10.1055/s-0033-1350907

Der interessante Fall

Georg Thieme Verlag KG Stuttgart · New York

Papillenschwellung, Hydrozephalus und Diplopie – kein zeitlicher, aber ein kausaler Zusammenhang?

Papilledema, Hydrocephalus and Diplopia – Not a Temporal but a Causal Connection?

F. Tonagel

¹Augenheilkunde, Universitätskliniken Tübingen

,

K. Friebe

²Neurologie, Universitätskliniken Tübingen

,

H. Wilhelm

¹Augenheilkunde, Universitätskliniken Tübingen

,

C. Kernstock

¹Augenheilkunde, Universitätskliniken Tübingen

Literatur
1 Bezo C, Majzoub S, Nochez Y et al. [Ocular and neuro-ophthalmic manifestations of sarcoidosis: Retrospective study of 30 cases]. J Fr Ophtalmol 2013; 36: 473-480
2 Menezo V, Lobo A, Yeo TK et al. Ocular features in neurosarcoidosis. Ocul Immunol Inflamm 2009; 17: 170-178
3 Phillips YL, Eggenberger ER. Neuro-ophthalmic sarcoidosis. Curr Opin Ophthalmol 2010; 21: 423-429
4 Koczman JJ, Rouleau J, Gaunt M et al. Neuro-ophthalmic sarcoidosis: the University of Iowa experience. Semin Ophthalmol 2008; 23: 157-168
5 Lamirel C, Badelon I, Gout O et al. [Neuro-ophthalmologic initial presentation of sarcoidosis]. J Fr Ophtalmol 2006; 29: 241-249
6 Yu-Wai-Man P, Crompton DE, Graham JY et al. Optic perineuritis as a rare initial presentation of sarcoidosis. Clin Experiment Ophthalmol 2007; 35: 682-684
7 Segal BM. Neurosarcoidosis: diagnostic approaches and therapeutic strategies. Curr Opin Neurol 2013; 26: 307-313
8 Takada K, Matsumoto S, Kojima E et al. Diagnostic management of patients with suspected ocular sarcoidosis. J Thorac Dis 2013; 5: 135-140
9 Marangoni S, Argentiero V, Tavolato B. Neurosarcoidosis. Clinical description of 7 cases with a proposal for a new diagnostic strategy. J Neurol 2006; 253: 488-495
10 Khoury J, Wellik KE, Demaerschalk BM et al. Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central nervous system sarcoidosis. Neurologist 2009; 15: 108-111
11 Grutters JC, Fellrath JM Mulder Let al. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation. Chest 2003; 124: 186-195
12 Frohman LP, Grigorian R, Bielory L. Neuro-ophthalmic manifestations of sarcoidosis: clinical spectrum, evaluation, and management. J Neuroophthalmol 2001; 21: 132-137